Search results
Jul 22, 2021 · But Sean McClain started Absci as a freshly minted grad from the University of Arizona at age 22, living with his parents and working out of a basement lab.
Sean McClain is the Founder and CEO of Absci, a leading generative AI Drug Creation company with a mission to create better biologics for patients, faster.
Apr 6, 2021 · Endpoints News names Sean McClain, CEO and founder of Absci, to its 20 Under Forty in Biopharma list.
Mar 24, 2022 · As CEO and founder of Absci (NASDAQ:ABSI), a drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins, Sean McClain has come a long way in the past 10 years.
View Sean McClain’s profile on LinkedIn, a professional community of 1 billion members. Experience: Absci · Education: University of Arizona · Location: Portland · 500+ connections on...
- 500+
- Absci
- 2.6K
- Portland, Oregon, United States
The McLean Company traces its history back to its founder Don H. McLean – father of the company’s current chairman of the board, Donald K. McLean, and vice chairman, Fred H. McLean, and grandfather to the current president, Donald S. McLean, his sister, Carey, and Fred H. McLean’s three sons, Scott, Doug, and Bill McLean.
Sean McClain, founder and CEO of Absci, started the company in 2011 with a bold goal to re-engineer E. coli to be an effective biomanufacturing system for twenty-first century biologics.